These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15692576)
1. Researchers probe the real effect of placebos. Katsnelson A Nat Med; 2005 Feb; 11(2):105. PubMed ID: 15692576 [No Abstract] [Full Text] [Related]
2. Placebo: art or science? Rankin-Box D Complement Ther Clin Pract; 2008 Aug; 14(3):149-51. PubMed ID: 18640625 [No Abstract] [Full Text] [Related]
3. The use of placebo in clinical nursing research. Chan CW; Thompson DR J Clin Nurs; 2006 May; 15(5):521-4. PubMed ID: 16629960 [TBL] [Abstract][Full Text] [Related]
4. Are there two studies that clearly reveal superiority of drug over placebo? Overall JE; Rhoades HM Psychopharmacol Bull; 1984; 20(1):64-7. PubMed ID: 6718653 [No Abstract] [Full Text] [Related]
5. Is the placebo powerless? Beldoch M N Engl J Med; 2001 Oct; 345(17):1278; author reply 1278-9. PubMed ID: 11680460 [No Abstract] [Full Text] [Related]
6. Placebo in clinical trials. Ito S Clin Pharmacol Ther; 2011 Nov; 90(5):637-9. PubMed ID: 22012308 [No Abstract] [Full Text] [Related]
7. Comments on 'Current issues in non-inferiority trials' by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855. Koch GG Stat Med; 2008 Feb; 27(3):333-42. PubMed ID: 17530625 [No Abstract] [Full Text] [Related]
8. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials. Tamura RN; Huang X Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design. Kohro T; Yamazaki T Hypertens Res; 2009 Feb; 32(2):109-14. PubMed ID: 19262468 [TBL] [Abstract][Full Text] [Related]
10. Randomization as a basis for inference in noninferiority trials. Wiens BL Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425 [TBL] [Abstract][Full Text] [Related]
11. Exploring the use of the sham design for interventional trials: implications for endoscopic research. Wilcox CM Gastrointest Endosc; 2008 Jan; 67(1):123-7. PubMed ID: 18155434 [No Abstract] [Full Text] [Related]
12. Current issues in non-inferiority trials. Fleming TR Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597 [TBL] [Abstract][Full Text] [Related]
16. Should we recruit patients or healthy volunteers for acupuncture studies of chronic pain? White P; Lewith G; Prescott P Clin J Pain; 2007 Oct; 23(8):714-9. PubMed ID: 17885351 [TBL] [Abstract][Full Text] [Related]
17. Re: Design and endpoints of clinical trials in hepatocellular carcinoma. Di Maio M; Daniele B; Gallo C; Perrone F J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679 [No Abstract] [Full Text] [Related]
18. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527 [TBL] [Abstract][Full Text] [Related]
19. Adaptive design may hasten clinical trials. Schmidt C J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993 [No Abstract] [Full Text] [Related]
20. How AIDS made patients act up. Brown P New Sci; 1992 Jun; 134(1824):21-2. PubMed ID: 16044591 [No Abstract] [Full Text] [Related] [Next] [New Search]